Bellerophon Therapeutics, Inc.
BLPH
BLPH was delisted on the 13th of October, 2023.
15 hedge funds and large institutions have $35.6M invested in Bellerophon Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
4.84% less ownership
Funds ownership: 57.22% → 52.39% (-4.8%)
25% less funds holding
Funds holding: 20 → 15 (-5)
39% less capital invested
Capital invested by funds: $58.6M → $35.6M (-$23M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMVA
New Mountain Vantage Advisers
New York
|
+$25M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$184K |
| 3 |
LPL Financial
San Diego,
California
|
+$173K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$156K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$29.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIG
Senator Investment Group
New York
|
-$2.53M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$1.1M |
| 3 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$912K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$283K |
| 5 |
Morgan Stanley
New York
|
-$102K |
BLPH Hedge Fund Activity: Q3 2015 in Review
15 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Bellerophon Therapeutics, Inc. (BLPH) for Q3 2015, worth a combined $35.6M — down 39% from $58.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BLPH and 3 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was New Mountain Vantage Advisers, opening a new position worth an estimated $25M. The largest seller was Senator Investment Group, exiting entirely with an estimated $2.53M sold.
- 15 institutional investors held Bellerophon Therapeutics, Inc. (BLPH) as of Q3 2015, down from 20 in Q2 2015.
- Funds reported $35.6M of Bellerophon Therapeutics, Inc. stock for Q3 2015, down 39% quarter-over-quarter.
- 3 funds opened new Bellerophon Therapeutics, Inc. positions in Q3 2015 and 7 closed out, a net change of -4 holders.
- The largest Bellerophon Therapeutics, Inc. buyer in Q3 2015 was New Mountain Vantage Advisers, an estimated $25M added.
- The largest Bellerophon Therapeutics, Inc. seller in Q3 2015 was Senator Investment Group, an estimated $2.53M sold.
Based on aggregated 13F filings for Q3 2015.